LAVI Share Price Performance
€0.80
0.05 (6.67%)
Price €0.80
Share Price€0.80
We Think Shareholders Should Be Aware Of Some Factors Beyond Lavipharm's (ATH:LAVI) Profit
Apr 10
Lavipharm S.A. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
LAVI Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Lavipharm S.A. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 17, 2025
- 0.012
- 45.50%
- 3.57%
- 38.2%
About LAVI
- Founded
- 1911
- Employees
- 282
- CEO
- WebsiteView website
Lavipharm S.A. engages in the research, development, manufacture, import, marketing, sale, and wholesale of pharmaceutical, cosmetics, and healthcare products to physicians and pharmacists in Greece and internationally. The company offers pharmaceutical products for cardiology, oncology-urology, central nervous system, chronic pain, and self- treatment. It also provides prescription medicines and over the counter (OTC) products, as well as LIFELAB CBD products. The company was founded in 1911 and is based in Paiania, Greece.